Fund VI


Size: EUR 1,900 million

Year: 2006

Investment focus/criteria:

Geographic scope:Primarily Nordic Region, selected investments in Europe Industries:Diversified, special focus on and expertise in healthcare investments Main focus:Large and medium-sized companies Key Characteristics:Opportunities for structural transformation, operational improvements, buy & build, emerging market growth, strategic repositioning, international expansion and growth acceleration.


Investors:

Investors in Nordic Capital Funds are 60 institutions, e.g. pension funds, banks and insurance companies. 

The Nordic region represents 20% of committed capital, Europe 30%,
the US 40% and rest of the world 10%.


General Partner Board of Directors:
Jean Le Creurer
Lynda Elliott
Keith Mackenzie
David Pirouet

Investments:
Investment year Company Industry Turnover (EUR m)* Exit
2005 Luvata > Metal solutions manufacturing and heat transfer technology 1570
2005 Nycomed Pharmaceuticals 2011
2006 Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.) Specialty pharmaceuticals 2012
2006 Brightpoint Mobile phone distributor 2007
2006 Menigo Food service distributor 2016
2006 Capio > Healthcare services 1470
2007 Unilabs > Laboratory and radiology services 670
2007 Thule Leisure, outdoor industry 580 2016
2007 Brink Group Towing systems 100 2015
2007 Nefab Packaging solutions provider 2014
2008 ConvaTec > Ostomy, wound care and hospital products 1490
2008 Chromaflo Technologies (Combination with CPS Color’s Colorant division) > Colorant systems 310
2008 Corob Colorant equipment 70 2016

* 2015 sales for companies still in portfolio; sales at exit for divested companies


Contact information:

Nordic Capital Limited
26 Esplanade, St Helier Jersey JE2 3QA
Tel: +44 1534 605 100
Fax: +44 1534 605 199
For all investor communications: investor@nordiccapital.je